3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
2
Gynecologic
2
Gastrointestinal
2
Conditions
Stomach Neoplasms
30
Peritoneal Neoplasms
24
Ovarian Neoplasms
24
Fallopian Tube Neoplasms
13
Carcinoma, Ovarian Epithelial
12
Colorectal Neoplasms
11
Neoplasm Metastasis
5
Appendiceal Neoplasms
5
Recurrence
3
Pancreatic Neoplasms
3
Neoplasms
3
Uterine Neoplasms
2
Sarcoma
2
Pseudomyxoma Peritonei
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastric Adenocarcinoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Carcinoma
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Stage â…¢ Gastric Cancer
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Peritoneal Diseases
1
Pelvic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Interventions
Pemetrexed
39
Cisplatin
33
pembrolizumab
21
Nivolumab
17
Carboplatin
16
Ipilimumab
13
Gemcitabine
10
Cyclophosphamide
9
fludarabine
6
durvalumab
6
Bevacizumab
6
Radiotherapy, Intensity-Modulated
4
LMB-100
4
Dexamethasone
4
tremelimumab
3
tazemetostat
3
spartalizumab
3
olaparib
3
niraparib
3
atezolizumab
3
anetumab ravtansine
3
amatuximab
3
Vinorelbine
3
Paclitaxel
3
Imatinib Mesylate
3
Cerebral Decortication
3
tislelizumab
2
sargramostim
2
fludarabine phosphate
2
defactinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Mesothelioma
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled